213 related articles for article (PubMed ID: 18254013)
21. Recurrent abdominal pain: symptom subtypes based on the Rome II Criteria for pediatric functional gastrointestinal disorders.
Walker LS; Lipani TA; Greene JW; Caines K; Stutts J; Polk DB; Caplan A; Rasquin-Weber A
J Pediatr Gastroenterol Nutr; 2004 Feb; 38(2):187-91. PubMed ID: 14734882
[TBL] [Abstract][Full Text] [Related]
22. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.
Chumpitazi BP; Kearns GL; Shulman RJ
Aliment Pharmacol Ther; 2018 Mar; 47(6):738-752. PubMed ID: 29372567
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Peppermint oil in diarrhea predominant IBS - a double blind randomized placebo - controlled study.
Alam MS; Roy PK; Miah AR; Mollick SH; Khan MR; Mahmud MC; Khatun S
Mymensingh Med J; 2013 Jan; 22(1):27-30. PubMed ID: 23416804
[TBL] [Abstract][Full Text] [Related]
24. Recurrent Abdominal Pain in Children: Summary Evidence From 3 Systematic Reviews of Treatment Effectiveness.
Abbott RA; Martin AE; Newlove-Delgado TV; Bethel A; Whear RS; Thompson Coon J; Logan S
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):23-33. PubMed ID: 29470291
[TBL] [Abstract][Full Text] [Related]
25. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data.
Alammar N; Wang L; Saberi B; Nanavati J; Holtmann G; Shinohara RT; Mullin GE
BMC Complement Altern Med; 2019 Jan; 19(1):21. PubMed ID: 30654773
[TBL] [Abstract][Full Text] [Related]
26. Recurrent abdominal pain in children revisited: irritable bowel syndrome and psychosomatic aspects. A prospective study.
Nygaard EA; Størdal K; Bentsen BS
Scand J Gastroenterol; 2004 Oct; 39(10):938-40. PubMed ID: 15513331
[TBL] [Abstract][Full Text] [Related]
27. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome: a 6-year prospective cohort study.
Cristofori F; Fontana C; Magistà A; Capriati T; Indrio F; Castellaneta S; Cavallo L; Francavilla R
JAMA Pediatr; 2014 Jun; 168(6):555-60. PubMed ID: 24756157
[TBL] [Abstract][Full Text] [Related]
28. A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.
Weerts ZZRM; Essers BAB; Jonkers DMAE; Willems JIA; Janssen DJPA; Witteman BJM; Clemens CHM; Westendorp A; Masclee AAM; Keszthelyi D
United European Gastroenterol J; 2021 Nov; 9(9):997-1006. PubMed ID: 34468079
[TBL] [Abstract][Full Text] [Related]
29. Psychological treatments for the management of irritable bowel syndrome.
Zijdenbos IL; de Wit NJ; van der Heijden GJ; Rubin G; Quartero AO
Cochrane Database Syst Rev; 2009 Jan; (1):CD006442. PubMed ID: 19160286
[TBL] [Abstract][Full Text] [Related]
30. Preoperative analgesics for additional pain relief in children and adolescents having dental treatment.
Ashley PF; Parekh S; Moles DR; Anand P; Behbehani A
Cochrane Database Syst Rev; 2012 Sep; (9):CD008392. PubMed ID: 22972120
[TBL] [Abstract][Full Text] [Related]
31. Acupuncture for treatment of irritable bowel syndrome.
Lim B; Manheimer E; Lao L; Ziea E; Wisniewski J; Liu J; Berman B
Cochrane Database Syst Rev; 2006 Oct; (4):CD005111. PubMed ID: 17054239
[TBL] [Abstract][Full Text] [Related]
32. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders.
Saps M; Youssef N; Miranda A; Nurko S; Hyman P; Cocjin J; Di Lorenzo C
Gastroenterology; 2009 Oct; 137(4):1261-9. PubMed ID: 19596010
[TBL] [Abstract][Full Text] [Related]
33. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J; Castells X; Ehimare UP; Smith CH
Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
[TBL] [Abstract][Full Text] [Related]
34. Homeopathy for treatment of irritable bowel syndrome.
Peckham EJ; Nelson EA; Greenhalgh J; Cooper K; Roberts ER; Agrawal A
Cochrane Database Syst Rev; 2013 Nov; (11):CD009710. PubMed ID: 24222383
[TBL] [Abstract][Full Text] [Related]
35. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine.
Symon DN; Russell G
Arch Dis Child; 1995 Jan; 72(1):48-50. PubMed ID: 7717738
[TBL] [Abstract][Full Text] [Related]
36. Paracetamol (acetaminophen) for prevention or treatment of pain in newborns.
Ohlsson A; Shah PS
Cochrane Database Syst Rev; 2015 Jun; (6):CD011219. PubMed ID: 26110914
[TBL] [Abstract][Full Text] [Related]
37. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine.
Christensen MF
Arch Dis Child; 1995 Aug; 73(2):183. PubMed ID: 7574874
[No Abstract] [Full Text] [Related]
38. Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial.
Nurko S; Saps M; Kossowsky J; Zion SR; Di Lorenzo C; Vaz K; Hawthorne K; Wu R; Ciciora S; Rosen JM; Kaptchuk TJ; Kelley JM
JAMA Pediatr; 2022 Apr; 176(4):349-356. PubMed ID: 35099543
[TBL] [Abstract][Full Text] [Related]
39. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
40. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
